Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5578)
All Articles published online
|
Oct 26, 2011 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nishio K, Kashiki S, Tachibana H, Kobayashi Y. Angiotensin-converting enzyme and bradykinin gene polymorphisms and cough: A meta-analysis. World J Cardiol 2011; 3(10): 329-336 [PMID: 22053221 DOI: 10.4330/wjc.v3.i10.329] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v3/i10/329.htm |
| Number | Citing Articles |
| 1 |
Jian-Quan Luo, Fa-Zhong He, Zhi-Ying Luo, Jia-Gen Wen, Lu-Yan Wang, Ning-Ling Sun, Gen-Fu Tang, Qing Li, Dong Guo, Zhao-Qian Liu, Hong-Hao Zhou, Xiao-Ping Chen, Wei Zhang. Rs495828 polymorphism of the ABO gene is a predictor of enalapril-induced cough in Chinese patients with essential hypertension. Pharmacogenetics and Genomics 2014; 24(6): 306 doi: 10.1097/FPC.0000000000000050
|
| 2 |
Pär Hallberg, Matilda Persson, Tomas Axelsson, Marco Cavalli, Pia Norling, Hans-Erik Johansson, Qun-Ying Yue, Patrik KE Magnusson, Claes Wadelius, Niclas Eriksson, Mia Wadelius. Genetic Variants Associated with Angiotensin-Converting Enzyme Inhibitor-Induced Cough: A Genome-Wide Association Study in a Swedish Population. Pharmacogenomics 2017; 18(3): 201 doi: 10.2217/pgs-2016-0184
|
| 3 |
You Komatsuzaki, Masato Ikeda, Akihiro Shimizu, Nanae Matsuo, Yukio Maruyama, Takashi Yokoo, Hiroyuki Yamamoto, Nobuhiko Joki, Ryoichi Ando, Daijo Inaguma, Toshihiko Yamaka, Masaaki Nakayama, Fumihiko Koiwa, Shinya Kawamoto, Shigeo Negi, Takashi Shigematsu. False-negative diagnosis of high anion gap in patients with end-stage kidney disease. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-84087-y
|
| 4 |
Min Gao, Yuli Wang, Yuzhi Shi, Dan Liu, Yin Liang, Yan Yu, Jiahui Zhaobin, Lili Zhu, Shoude Jin. The relationship between three well-characterized polymorphisms of the angiotensin converting enzyme gene and lung cancer risk: a case-control study and a meta-analysis. Journal of the Renin-Angiotensin-Aldosterone System 2012; 13(4): 455 doi: 10.1177/1470320312443912
|
| 5 |
Masato Ikeda, Masatsugu Nakao, Keita Hirano, Keitaro Yokoyama, Takashi Yokoo, Nobuhiko Joki, Ryoichi Ando, Toshio Shinoda, Daijo Inaguma, Toshihiko Yamaka, Yasuhiro Komatsu, Fumihiko Koiwa, Toshifumi Sakaguchi, Shigeo Negi, Takashi Shigematsu. Possible prevention of dialysis-requiring congestive heart failure by angiotensin-II receptor blockers in non-dialysis Japanese patients with Stage 5 chronic kidney disease. Journal of the Renin-Angiotensin-Aldosterone System 2015; 16(4): 1175 doi: 10.1177/1470320315592565
|
| 6 |
Hong Wang, Kun Zhang, Haifeng Qin, Lin Yang, Liyu Zhang, Yanyan Cao. Genetic Association Between CD143 rs4340 Polymorphism and Pneumonia risk. Medicine 2015; 94(30): e883 doi: 10.1097/MD.0000000000000883
|
| 7 |
Philip G. Joseph, Guillaume Pare, Stephanie Ross, Robert Roberts, Sonia S. Anand. Pharmacogenetics in Cardiovascular Disease: The Challenge of Moving From Promise to Realization. Clinical Cardiology 2014; 37(1): 48 doi: 10.1002/clc.22200
|
| 8 |
Ya-Feng Li, Xiao-Ming Zhu, Fan Liu, Chuan-Shi Xiao, Yun-Fei Bian, Hong Li, Jun Cai, Rong-Shan Li, Xin-Chun Yang, Giuseppe Biondi-Zoccai. Angiotensin-Converting Enzyme (ACE) Gene Insertion/Deletion Polymorphism and ACE Inhibitor-Related Cough: A Meta-Analysis. PLoS ONE 2012; 7(6): e37396 doi: 10.1371/journal.pone.0037396
|
| 9 |
Seyed Hamidreza Mahmoudpour, Maarten Leusink, Lisa van der Putten, Ingrid Terreehorst, Folkert W Asselbergs, Anthonius de Boer, Anke H Maitland-van der Zee. Pharmacogenetics of ACE Inhibitor-Induced Angioedema and Cough: a Systematic Review and Meta-Analysis. Pharmacogenomics 2013; 14(3): 249 doi: 10.2217/pgs.12.206
|
| 10 |
Heba Abouzeid, Usama M. Alkholy, Mohammed A. Abdou, Saeed M. Morsy, Hind M. Abdelrahman, Ashraf M. Sherif, Nermin Abdalmonem, Mohammed E. Hamed, Mayy A.N. Allah, Salah Al Morshedy, Shaimaa S.A. Elashkar, Maha A. Noah, Mohamed S. Hegab, Nagwa E. Akeel, Mustafa I.A. Hashem, Heba H. Gawish, Lobna Abdel Fattah. Angiotensin‐converting enzyme insertion/deletion gene polymorphism in Egyptian children with CAP: A case‐control study. Pediatric Pulmonology 2017; 52(12): 1592 doi: 10.1002/ppul.23886
|
| 11 |
Kensuke Kondo, Ryuji Toh, Tatsuro Ishida, Kenta Mori, Tomoyuki Yasuda, Ken-ichi Hirata. Comparison of telmisartan/amlodipine and telmisartan/hydrochlorothiazide in the treatment of Japanese patients with uncontrolled hypertension. Blood Pressure Monitoring 2016; 21(3): 171 doi: 10.1097/MBP.0000000000000172
|
| 12 |
Lyubov E. Salnikova, Tamara V. Smelaya, Viktor V. Moroz, Arkadiy M. Golubev, Alexander V. Rubanovich. Functional polymorphisms in the CYP1A1, ACE, and IL-6 genes contribute to susceptibility to community-acquired and nosocomial pneumonia. International Journal of Infectious Diseases 2013; 17(6): e433 doi: 10.1016/j.ijid.2013.01.005
|
| 13 |
Jean-Pierre Girolami, Nelly Blaes, Nadine Bouby, François Alhenc-Gelas. Recent Developments in the Regulation of Kinins. 2014; : 145 doi: 10.1007/978-3-319-06683-7_6
|
| 14 |
Ivan V. Sychev, Natalia P. Denisenko, Anastasiya A. Kachanova, Anna V. Lapshtaeva, Sherzod P. Abdullaev, Ludmila N. Goncharova, Karin B. Mirzaev, Dmitry A. Sychev. Pharmacogenetic markers of development of angioneurotic edema as a secondary side effect to enalapril in patients with essential arterial hypertension. International Journal of Risk & Safety in Medicine 2024; 35(1): 37 doi: 10.3233/JRS-230006
|
| 15 |
Ye Yuan, Lin Meng, Yan Zhou, Na Lu. Genetic polymorphism of angiotensin-converting enzyme and hypertrophic cardiomyopathy risk. Medicine 2017; 96(48): e8639 doi: 10.1097/MD.0000000000008639
|
| 16 |
Atsuhisa Sato, Seiichi Fukuda. A prospective study of frequency and characteristics of cough during ACE inhibitor treatment. Clinical and Experimental Hypertension 2015; 37(7): 563 doi: 10.3109/10641963.2015.1026040
|
| 17 |
Mohammad Saifur Rohman, Jonny Karunia Fajar, Bagus Hery Kuncahyo, Lowry Yunita, Erdo Puncak Sidarta, Putu Nina Belinda Saka, Teuku Heriansyah, Nashi Widodo. Angiotensin-converting enzyme (ACE) I/D and bradykinin B2 receptor T/C genes polymorphism in patients with ACE inhibitors-related cough. Egyptian Journal of Medical Human Genetics 2018; 19(4): 307 doi: 10.1016/j.ejmhg.2018.05.006
|
| 18 |
Georges Nemer, Nagham Nafiz Hendi. Pharmacogenomics and Pharmacogenetics in Drug Therapy. Pharmaceutical Science 2024; 3 doi: 10.5772/intechopen.113236
|
| 19 |
Michael Abonyi, U C Okechukwu , C M Ezeude . Prevalence and Risk Factors for Angiotensin Converting Enzyme Inhibitor Induced Cough among Diabetic Patients in a Tertiary Institution in Southeast Nigeria. International Journal of Medical Sciences and Pharma Research 2023; 9(4): 1 doi: 10.22270/ijmspr.v9i4.78
|
| 20 |
Xiaofang Zhang, Fangzhu Liu. Increased risk of pneumonia associated with angiotensin-converting enzyme (CD143) rs4340 polymorphism. Clinical and Experimental Medicine 2016; 16(3): 423 doi: 10.1007/s10238-015-0356-3
|
| 21 |
Jianmin Yang, Yunhan Zhao, Panpan Hao, Xiao Meng, Mei Dong, Ying Wang, Yun Zhang, Cheng Zhang, Katriina Aalto-Setala. Impact of Angiotensin I Converting Enzyme Insertion/Deletion Polymorphisms on Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy Risk. PLoS ONE 2013; 8(5): e63309 doi: 10.1371/journal.pone.0063309
|
| 22 |
Fumiki Yoshihara, Hiroshi Ohtsu, Michikazu Nakai, Shinya Tsuzuki, Kayoko Hayakawa, Mari Terada, Nobuaki Matsunaga, Satoshi Yasuda, Hisao Ogawa, Norio Ohmagari. Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry Japan. Journal of Cardiology 2022; 80(4): 292 doi: 10.1016/j.jjcc.2022.04.001
|